Cite
APA Citation
French, J. A., Cole, A. J., Faught, E., Theodore, W. H., Vezzani, A., Liow, K., Halford, J. J., Armstrong, R., Szaflarski, J. P., Hubbard, S., Patel, J., Chen, K., Feng, W., Rizzo, M., Elkins, J., Knafler, G., & Parkerson, K. A. (2021). safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy. Neurology, 97, e1757–e1767. http://access.bl.uk/ark:/81055/vdc_100146100796.0x00003b